NNOX Nano X Imaging

NANO-X IMAGING LTD Files 2020 Annual Report on Form 20-F

NANO-X IMAGING LTD Files 2020 Annual Report on Form 20-F

NEVE ILAN, Israel, April 06, 2021 (GLOBE NEWSWIRE) -- (“Nanox” or the “Company”), the innovative medical imaging technology company democratizing healthcare, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission (“SEC”) on April 6, 2021. The annual report on Form 20-F, which contains the Company’s audited consolidated financial statements, can be accessed on the SEC’s website at  and on the Company’s website at  under “Financials” in the Investors section.

The Company will provide a hard copy of its annual report containing its audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed to Investor Relations, at .

About NANO-X:

Nano-X, founded by the serial entrepreneur Ran Poliakine is an Israeli corporation developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nano-X believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all. For more information, please visit .

Contact:

Itzhak Maayan

Nanox Imaging

Bob Yedid

LifeSci Advisors



EN
06/04/2021

Underlying

NNOXNano X Imaging

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nano X Imaging

 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox Signs Distribution Agreement with Imperial Imaging Technology to...

Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast Agreement with Imperial Imaging strengthens Nanox’s commercial rollout across the orthopedic-rich segment in six U.S. Southeast states. Distribution Agreement Supports U.S. Market Expansion PETACH TIKVA, Israel, March 03, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its US-based subsidiary, Nanox Impact Inc. has signed a new distribution agreement with LLC, a Georgia based provider of diagnostic imagin...

March 3, 2026 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution A...

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution Agreement in Argentina Collaboration with Intec SRL drives commercial expansion of 3D medical imaging across a high-growth private healthcare market PETACH TIKVA, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- (“Nanox”, Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced a distribution agreement with Intec SRL, an Argentina-based medical device distributor with more than 35 years of experience delivering advanced imaging technologies to healthcare providers nationwide. The is a multi-source d...

February 19, 2026 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox to Showcase Nanox.ARC Live in Europe for First Time and Present ...

Nanox to Showcase Nanox.ARC Live in Europe for First Time and Present New AI Capabilities at ECR 2026 Live demonstrations of the Nanox.ARC will feature at the ECR booth #425 in Hall X4Oral presentation by Dr. Nogah Shabshin to present data on potential role of digital tomosynthesis in lung cancer screeningOral presentation by Dr. Orit Wimpfheimer to explore how Nanox AI transforms routine CT scans into tools for early detection of cardiovascular disease, osteoporosis and fatty liver diseasePoster presentations to highlight new clinical data from ADOPT study featuring AI bone solution PETAC...

February 17, 2026 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Ca...

Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems This clearance enables the next phase of development aimed ultimately at removing the adjunct use in the US The newly cleared capability provides radiologists with a 2D image generated directly from the tomosynthesis scan, enabling both 3D and 2D views from a single scan, without exposing the patient to any additional radiation PETACH TIKVA, Israel – February 3 – (“Nanox” or the “Company”) today announced that the United States Food and Drug Administration (FDA) has gran...

February 3, 2026 1 EN
 PRESS RELEASE
Free
NNOX NANO X IMAGING

Nanox Expands in Europe with New Nanox.ARC Distribution Engagement in ...

Nanox Expands in Europe with New Nanox.ARC Distribution Engagement in Serbia, Montenegro, and Bosnia and Herzegovina Collaboration with Adriamed drives commercial expansion and strengthens Nanox’s regional leadership Engagement supports continued growth across multiple European markets, following recent collaborations in Greece, Romania, and PETACH TIKVA, ISRAEL – January 14, 2026 – (“Nanox”, Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced a new collaboration with (“Adriamed”), a Belgrade-based medical device distributor serving healthcare providers a...

January 14, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch